Guidelines for the Diagnosis and Management of Familial Long QT Syndrome

Heart Lung and Circulation

Volumn 16, Issue 1, 2007, Pages 22-24

  Skinner, Jon R ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; FLECAINIDE; NADOLOL; NICORANDIL; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE;

ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR MODIFICATION; CLINICAL FEATURE; DEFIBRILLATION; DIAGNOSTIC ERROR; ELECTROCARDIOGRAPHY; EPILEPSY; FAMILY COUNSELING; FAMILY HISTORY; FAMILY STUDY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEART ARREST; HUMAN; LONG QT SYNDROME; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESUSCITATION; SPORT; SUDDEN DEATH; SYMPATHECTOMY; SYNCOPE;

EID: 33846415827     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2006.10.021     Document Type: Article

References (5)

1. I.A. Khan Clinical and therapeutic aspects of congenital and acquired long QT syndrome Am J Med 112 2002 58 66 [review article]
2. P.J. Schwartz S.G. Priori C. Spazzolini A.J. Moss G.M. Vincent C. Napolitano Genotype-phenotype correlation in the long QT syndrome: gene-specific triggers for life-threatening arrhythmias Circulation 103 2001 89 95
3. A.J. Moss W. Zareba W.J. Hall P.J. Schwartz R.S. Crampton J. Benhorin Effectiveness and limitations of beta-blocker therapy in congenital long QT syndrome Circulation 101 2000 616 623
4. S.G. Priori P.J. Schwartz C. Napolitano R. Bloise E. Ronchetti M. Grillo Risk stratification in the long-QT syndrome N Engl J Med 348 19 2003 1866 1874
5. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 10 2004 1013 1022